or Try an Advanced Search...

    ETF Components for PPH - Market Vectors Pharmaceutical ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    LLY B -0.95 13.10
    NVO C -2.87 10.11
    MRK C -1.46 5.97
    JNJ F -0.23 5.95
    ABBV C -1.28 5.48
    NVS A 0.32 5.05
    AZN C -0.25 4.91
    MCK B -0.25 4.59
    HLN B 1.56 4.58
    BMY F -0.96 4.49
    SNY B 0.66 4.47
    PFE D -0.47 4.44
    ZTS C 0.45 4.35
    TAK F 0.61 4.34
    GSK D 0.65 4.23
    TEVA B 1.63 3.25
    VTRS F -0.48 1.55
    JAZZ F -1.48 0.95
    ELAN F 0.86 0.90
    CTLT B 0.55 0.78
    OGN C 0.94 0.71
    PRGO D 0.77 0.45
    PDCO F -0.08 0.26

    Represented by ETF Holdings

    Keywords: Pharmaceutical Products S&P 500 Pharmaceutical Animal Health Life Sciences Antibiotics Biopharmaceutical Cancer Drugs Medication Pain Biotechnology Depressive Disorder Diabetes Hypertension Infection Infectious Diseases Active Pharmaceutical Ingredients Gastrointestinal Health Products
    Industries: Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Biotechnology Medical Distribution Drug Manufacturers - General

    Recent News for Market Vectors Pharmaceutical ETF & its Holdings

    Date Stock Title
    Jul 3 ABBV AbbVie Q2 IPR&D expenses to lower EPS by $0.52
    Jul 3 GSK GSk snaps six straight days of losses
    Jul 3 LLY Lilly's new Alzheimer's drug could generate $7.1B in sales: analyst
    Jul 3 NVO S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
    Jul 3 LLY S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
    Jul 3 NVO Using Obesity Drugs? Potential Vision Loss Disorder Linked To Novo Nordisk's Ozempic And Wegovy, Study Finds
    Jul 3 LLY Novo Nordisk, Eli Lilly Tumble After Study Suggests Weight-Loss Drugs Can Lead To Blindness
    Jul 3 NVO Novo Nordisk, Eli Lilly Tumble After Study Suggests Weight-Loss Drugs Can Lead To Blindness
    Jul 3 LLY Weight-loss drugs linked to rare vision loss: Harvard study
    Jul 3 NVO Weight-loss drugs linked to rare vision loss: Harvard study
    Jul 3 NVO Update: Ozempic, Wegovy Linked to Risk of Blinding Eye Condition, Study Shows
    Jul 3 NVO Novo Nordisk’s Ozempic, Wegovy linked to eye disorder in small study
    Jul 3 LLY ADP jobs data, Constellation Brands, summer gas prices: Morning Brief
    Jul 3 NVO Ozempic Linked to Rare Cases of Vision Loss in Harvard Study
    Jul 3 LLY Ozempic Linked to Rare Cases of Vision Loss in Harvard Study
    Jul 3 NVO Ozempic, Wegovy Linked to Risk of Blinding Eye Condition, Study Shows
    Jul 3 LLY FDA Approves Eli Lilly's Alzheimer's Drug Kisunla
    Jul 3 SNY Bain, Cinven Weighing Joint Bid for $20 Billion Sanofi Unit
    Jul 3 MRK Merck: Among The Best Health Care GARP Plays Today
    Jul 3 JNJ Johnson & Johnson: A Lot Of Moving Parts, But Perhaps Finally Lurching In The Right Direction
    The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors US Listed Pharmaceutical 25 Index (the "Pharmaceutical Index"). The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Pharmaceutical Index is comprised of common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
    Exchange Traded Fund ETF Stock Market Index Depositary Receipt
    Back to the Main PPH Page...